Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 2:5:49.
doi: 10.1038/s41525-020-00155-8. eCollection 2020.

Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing

Affiliations

Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing

Stephen F Kingsmore et al. NPJ Genom Med. .

Abstract

Understanding causes of infant mortality shapes public health policy and prioritizes diseases for investments in surveillance, intervention and medical research. Rapid genomic sequencing has created a novel opportunity to decrease infant mortality associated with treatable genetic diseases. Herein, we sought to measure the contribution of genetic diseases to mortality among infants by secondary analysis of babies enrolled in two clinical studies and a systematic literature review. Among 312 infants who had been admitted to an ICU at Rady Children's Hospital between November 2015 and September 2018 and received rapid genomic sequencing, 30 (10%) died in infancy. Ten (33%) of the infants who died were diagnosed with 11 genetic diseases. The San Diego Study of Outcomes in Mothers and Infants platform identified differences between in-hospital and out-of-hospital causes of infant death. Similarly, in six published studies, 195 (21%) of 918 infant deaths were associated with genetic diseases by genomic sequencing. In 195 infant deaths associated with genetic diseases, locus heterogeneity was 70%. Treatment guidelines existed for 70% of the genetic diseases diagnosed, suggesting that rapid genomic sequencing has substantial potential to decrease infant mortality among infants in ICUs. Further studies are needed in larger, comprehensive, unbiased patient sets to determine the generalizability of these findings.

Keywords: Molecular medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interestsD.D. received funding from Biomarin (consultant for Pegvaliase trials), Audentes Therapeutics (Scientific Advisory Board), and Ichorion Therapeutics (consultant for mitochondrial disease drugs). The remaining authors declare no competing interests.

References

    1. Murphy, S. L., Xu, J., Kochanek, K. D. & Arias, E. Mortality in the United States, 2017. NCHS Data Brief. 1–8 (2018). - PubMed
    1. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. Natl. Vital Stat. Rep. 2010;58:1–19. - PubMed
    1. Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. Natl Vital Stat. Rep. 1999;47:1–104. - PubMed
    1. MacDorman, M. F. & Rosenberg, H. M. Trends in infant mortality by cause of death and other characteristics, 1960-88. National Center for Health Statistics. Vital Health Stat.20 (1993). - PubMed
    1. Adeyinka, A. & Bailey, K. Death, Certification. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2019).